359 related articles for article (PubMed ID: 2507378)
21. Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition.
Gillon KR; Hawthorne JN; Tomlinson DR
Diabetologia; 1983 Oct; 25(4):365-71. PubMed ID: 6416913
[TBL] [Abstract][Full Text] [Related]
22. Glucose-induced microvascular functional changes in nondiabetic rats are stereospecific and are prevented by an aldose reductase inhibitor.
Williamson JR; Ostrow E; Eades D; Chang K; Allison W; Kilo C; Sherman WR
J Clin Invest; 1990 Apr; 85(4):1167-72. PubMed ID: 2108189
[TBL] [Abstract][Full Text] [Related]
23. [Diabetic changes in pupillary reaction and iridal pathology. No. 1. The role of aldose reductase to the delayed pupillary reaction in galactose-fed rats].
Terubayashi H; Akagi Y; Kador PF; Kinoshita JH
Nippon Ganka Gakkai Zasshi; 1988 Mar; 92(3):484-8. PubMed ID: 3137794
[No Abstract] [Full Text] [Related]
24. Discordant effects of the aldose reductase inhibitor, sorbinil, on vascular structure and function in chronically diabetic and galactosemic rats.
Tilton RG; Pugliese G; LaRose LS; Faller AM; Chang K; Province MA; Williamson JR
J Diabet Complications; 1991; 5(4):230-7. PubMed ID: 1779018
[TBL] [Abstract][Full Text] [Related]
25. Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil.
Beyer-Mears A; Ku L; Cohen MP
Diabetes; 1984 Jun; 33(6):604-7. PubMed ID: 6427041
[TBL] [Abstract][Full Text] [Related]
26. Increased sciatic nerve blood flow in diabetic rats: assessment by "molecular" vs. particulate microspheres.
Chang K; Ido Y; LeJeune W; Williamson JR; Tilton RG
Am J Physiol; 1997 Jul; 273(1 Pt 1):E164-73. PubMed ID: 9252493
[TBL] [Abstract][Full Text] [Related]
27. [Diabetic changes in pupillary reactions and iris histology. No. 3. The role of aldose reductase inhibitor to iridal vessel hyperpermeability of galactose-fed rats].
Kador PF; Kinoshita JH; Terubayashi H; Akagi Y; Kador PF; Kinoshita JH
Nippon Ganka Gakkai Zasshi; 1988 Oct; 92(10):1577-81. PubMed ID: 3145680
[No Abstract] [Full Text] [Related]
28. The effects of aldose reductase inhibition on nerve sorbitol and myoinositol concentrations in diabetic and galactosemic rats.
Yue DK; Hanwell MA; Satchell PM; Handelsman DJ; Turtle JR
Metabolism; 1984 Dec; 33(12):1119-22. PubMed ID: 6438438
[TBL] [Abstract][Full Text] [Related]
29. Effects of aldose reductase inhibitor sorbinil on neuroaxonal dystrophy and levels of myo-inositol and sorbitol in sympathetic autonomic ganglia of streptozocin-induced diabetic rats.
Schmidt RE; Plurad SB; Sherman WR; Williamson JR; Tilton RG
Diabetes; 1989 May; 38(5):569-79. PubMed ID: 2497038
[TBL] [Abstract][Full Text] [Related]
30. Effects of polyol-pathway inhibition and dietary myo-inositol on glomerular hemodynamic function in experimental diabetes mellitus in rats.
Goldfarb S; Ziyadeh FN; Kern EF; Simmons DA
Diabetes; 1991 Apr; 40(4):465-71. PubMed ID: 2010046
[TBL] [Abstract][Full Text] [Related]
31. The effect of aldose reductase inhibition on motor nerve conduction velocity in diabetic rats.
Yue DK; Hanwell MA; Satchell PM; Turtle JR
Diabetes; 1982 Sep; 31(9):789-94. PubMed ID: 6819173
[TBL] [Abstract][Full Text] [Related]
32. Diabetes-induced increases in vascular permeability and changes in granulation tissue levels of sorbitol, myo-inositol, chiro-inositol, and scyllo-inositol are prevented by sorbinil.
Williamson JR; Chang K; Rowold E; Marvel J; Tomlinson M; Sherman WR; Ackermann KE; Kilo C
Metabolism; 1986 Apr; 35(4 Suppl 1):41-5. PubMed ID: 3959907
[TBL] [Abstract][Full Text] [Related]
33. [Effect of aldose reductase inhibitor (M79175) on the oscillatory potential in ERG of streptozotocin-fructose induced diabetic rats].
Funada M; Okamoto I; Fujinaga Y; Yamana T
Nippon Ganka Gakkai Zasshi; 1985 Oct; 89(10):1111-9. PubMed ID: 3938182
[No Abstract] [Full Text] [Related]
34. Development of potent aldose reductase inhibitors having a hydantoin structure.
Miwa I; Hirano M; Inagaki K; Belbeoc'h C; Okuda J
Biochem Pharmacol; 1987 Sep; 36(17):2789-94. PubMed ID: 3115267
[TBL] [Abstract][Full Text] [Related]
35. AL-1576, an aldose reductase inhibitor (ARI), did not prevent the decrease of norepinephrine turnover in diabetic rats.
Yen TT; Fuller RW; Broderick CL; Hemrick-Luecke SK; Perry KW
Res Commun Chem Pathol Pharmacol; 1988 Aug; 61(2):257-60. PubMed ID: 3141993
[TBL] [Abstract][Full Text] [Related]
36. Prevention of neural myoinositol depletion in diabetic rats by aldose reductase inhibition with tolrestat.
Kemper C; Dvornik D
Proc Soc Exp Biol Med; 1986 Sep; 182(4):505-10. PubMed ID: 3090558
[TBL] [Abstract][Full Text] [Related]
37. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil.
Whiting PH; Ross IS
Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396
[TBL] [Abstract][Full Text] [Related]
38. Sorbinil prevents diabetes-induced increases in vascular permeability but does not alter collagen cross-linking.
Williamson JR; Chang K; Rowold E; Marvel J; Tomlinson M; Sherman WR; Ackermann KE; Kilo C
Diabetes; 1985 Jul; 34(7):703-5. PubMed ID: 4007287
[TBL] [Abstract][Full Text] [Related]
39. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
[TBL] [Abstract][Full Text] [Related]
40. Diabetic complications in lens and nerve and their prevention by sulindac or sorbinil: two novel aldose reductase inhibitors.
Jacobson M; Sharma YR; Cotlier E; Hollander JD
Invest Ophthalmol Vis Sci; 1983 Oct; 24(10):1426-9. PubMed ID: 6413448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]